Compare, Analyse Cipla with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs TEVA PHARMA (Israel) - Comparison Results

CIPLA     Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CIPLA   TEVA PHARMA
EQUITY SHARE DATA
    CIPLA
Mar-20
TEVA PHARMA
Dec-13
CIPLA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs5863,019-   
Low Rs3572,623-   
Sales per share (Unadj.) Rs207.01,732.9-  
Earnings per share (Unadj.) Rs18.6108.3-  
Cash flow per share (Unadj.) Rs33.2248.3-  
Dividends per share (Unadj.) Rs4.0094.77-  
Dividend yield (eoy) %0.83.4 25.3%  
Book value per share (Unadj.) Rs195.51,924.9-  
Shares outstanding (eoy) m806.35848.00-   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.31.6 139.8%   
Avg P/E ratio x25.326.1 97.2%  
P/CF ratio (eoy) x14.211.4 125.0%  
Price / Book Value ratio x2.41.5 164.4%  
Dividend payout %21.587.5 24.6%   
Avg Mkt Cap Rs m379,9122,392,428 15.9%   
No. of employees `00025.844.9 57.5%   
Total wages/salary Rs m30,2700-   
Avg. sales/employee Rs Th6,459.632,695.8 19.8%   
Avg. wages/employee Rs Th1,171.20-   
Avg. net profit/employee Rs Th580.22,042.5 28.4%   
INCOME DATA
Net Sales Rs m166,9491,469,515 11.4%  
Other income Rs m3,4420-   
Total revenues Rs m170,3911,469,515 11.6%   
Gross profit Rs m32,060402,427 8.0%  
Depreciation Rs m11,747118,782 9.9%   
Interest Rs m1,97428,864 6.8%   
Profit before tax Rs m21,782254,781 8.5%   
Minority Interest Rs m-4751,157 -41.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-167,250 0.0%   
Tax Rs m6,312-3,111 -202.9%   
Profit after tax Rs m14,99591,799 16.3%  
Gross profit margin %19.227.4 70.1%  
Effective tax rate %29.0-1.2 -2,373.5%   
Net profit margin %9.06.2 143.8%  
BALANCE SHEET DATA
Current assets Rs m117,038992,505 11.8%   
Current liabilities Rs m43,931865,548 5.1%   
Net working cap to sales %43.88.6 506.9%  
Current ratio x2.71.1 232.3%  
Inventory Days Days9691 105.4%  
Debtors Days Days8596 88.7%  
Net fixed assets Rs m107,424479,976 22.4%   
Share capital Rs m1,6133,617 44.6%   
"Free" reserves Rs m156,0180-   
Net worth Rs m157,6301,632,352 9.7%   
Long term debt Rs m23,693751,396 3.2%   
Total assets Rs m236,6263,358,312 7.0%  
Interest coverage x12.09.8 122.5%   
Debt to equity ratio x0.20.5 32.7%  
Sales to assets ratio x0.70.4 161.2%   
Return on assets %7.23.6 199.6%  
Return on equity %9.55.6 169.2%  
Return on capital %12.84.9 260.4%  
Exports to sales %33.00-   
Imports to sales %00-   
Net fx Rs m49,2720-   
CASH FLOW
From Operations Rs m30,685234,165 13.1%  
From Investments Rs m1,040-82,974 -1.3%  
From Financial Activity Rs m-29,488-280,896 10.5%  
Net Cashflow Rs m2,340-129,706 -1.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 72.34 Rs / USD

Compare CIPLA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare CIPLA With: GSK PHARMA  FRESENIUS KABI ONCO.  DR. DATSONS LABS  FDC  LUPIN  



Today's Market

Sensex Zooms 1,030 Points, Nifty Tops 14,980-Mark; HDFC Bank Among Top Gainers(Closing)

Indian share markets witnessed huge buying interest during the extended closing hours today and ended their day on a strong note.

Related Views On News

CIPLA Announces Quarterly Results (3QFY21); Net Profit Up 112.8% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2019-20 Annual Report Analysis (Annual Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

Here's an analysis of the annual report of CIPLA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

CIPLA Announces Quarterly Results (1QFY21); Net Profit Up 21.4% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, CIPLA has posted a net profit of Rs 6 bn (up 21.4% YoY). Sales on the other hand came in at Rs 43 bn (up 7.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 9, 2019 | Updated on Sep 9, 2019

Here's an analysis of the annual report of CIPLA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

More Views on News

Most Popular

Intraday Trading for a Living (Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Penny Stock Master Series: The Quest for 10X Profits in 10 Years (Profit Hunter)

Feb 12, 2021

This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Access Now: Eight Steps to Your Eight Figure Fortune
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

CIPLA SHARE PRICE


Feb 24, 2021 (Close)

TRACK CIPLA

MORE ON CIPLA

CIPLA 8-QTR ANALYSIS

COMPARE CIPLA WITH

FEATURED VIDEOS

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

Nasdaq & Nifty Could Reverse

Don't Fall for the 'Best Sector of 2021' Story

More Featured Videos

MARKET STATS